377 related articles for article (PubMed ID: 37572494)
1. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
[TBL] [Abstract][Full Text] [Related]
2. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
[TBL] [Abstract][Full Text] [Related]
3. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
[TBL] [Abstract][Full Text] [Related]
4. Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes.
Sadrabadi F; Alarcan J; Sprenger H; Braeuning A; Buhrke T
Arch Toxicol; 2024 Feb; 98(2):507-524. PubMed ID: 38117326
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the individual and combined toxicity of perfluoroalkyl substances to human liver cells using biomarkers of oxidative stress.
Ojo AF; Xia Q; Peng C; Ng JC
Chemosphere; 2021 Oct; 281():130808. PubMed ID: 34022600
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional effects of binary combinations of PFAS in FaO cells.
Bjork JA; Dawson DA; Krogstad JO; Wallace KB
Toxicology; 2021 Dec; 464():152997. PubMed ID: 34695511
[TBL] [Abstract][Full Text] [Related]
7. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
[TBL] [Abstract][Full Text] [Related]
8. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
Li X; Wang Z; Klaunig JE
Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
[TBL] [Abstract][Full Text] [Related]
9. Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorononanoic acid (PFNA) increase triglyceride levels and decrease cholesterogenic gene expression in human HepaRG liver cells.
Louisse J; Rijkers D; Stoopen G; Janssen A; Staats M; Hoogenboom R; Kersten S; Peijnenburg A
Arch Toxicol; 2020 Sep; 94(9):3137-3155. PubMed ID: 32588087
[TBL] [Abstract][Full Text] [Related]
10. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
Ojo AF; Peng C; Ng JC
Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
[TBL] [Abstract][Full Text] [Related]
11. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin.
Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S
Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022
[TBL] [Abstract][Full Text] [Related]
12. Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury.
Roth K; Yang Z; Agarwal M; Liu W; Peng Z; Long Z; Birbeck J; Westrick J; Liu W; Petriello MC
Environ Int; 2021 Dec; 157():106843. PubMed ID: 34479135
[TBL] [Abstract][Full Text] [Related]
13. The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.
Marques ES; Agudelo J; Kaye EM; Modaresi SMS; Pfohl M; Bečanová J; Wei W; Polunas M; Goedken M; Slitt AL
Toxicology; 2021 Oct; 462():152921. PubMed ID: 34464680
[TBL] [Abstract][Full Text] [Related]
14. Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress.
Omoike OE; Pack RP; Mamudu HM; Liu Y; Strasser S; Zheng S; Okoro J; Wang L
Environ Res; 2021 May; 196():110361. PubMed ID: 33131681
[TBL] [Abstract][Full Text] [Related]
15. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
[TBL] [Abstract][Full Text] [Related]
16. Early menarche and other endocrine disrupting effects of per- and polyfluoroalkyl substances (PFAS) in adolescents from Northern Norway. The Fit Futures study.
Averina M; Huber S; Almås B; Brox J; Jacobsen BK; Furberg AS; Grimnes G
Environ Res; 2024 Feb; 242():117703. PubMed ID: 37984785
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput Transcriptomic Analysis of Human Primary Hepatocyte Spheroids Exposed to Per- and Polyfluoroalkyl Substances as a Platform for Relative Potency Characterization.
Rowan-Carroll A; Reardon A; Leingartner K; Gagné R; Williams A; Meier MJ; Kuo B; Bourdon-Lacombe J; Moffat I; Carrier R; Nong A; Lorusso L; Ferguson SS; Atlas E; Yauk C
Toxicol Sci; 2021 May; 181(2):199-214. PubMed ID: 33772556
[TBL] [Abstract][Full Text] [Related]
18. Exposure to low-dose perfluorooctanoic acid promotes hepatic steatosis and disrupts the hepatic transcriptome in mice.
Attema B; Janssen AWF; Rijkers D; van Schothorst EM; Hooiveld GJEJ; Kersten S
Mol Metab; 2022 Dec; 66():101602. PubMed ID: 36115532
[TBL] [Abstract][Full Text] [Related]
19. Association of Combined Per- and Polyfluoroalkyl Substances and Metals with Chronic Kidney Disease.
Haruna I; Obeng-Gyasi E
Int J Environ Res Public Health; 2024 Apr; 21(4):. PubMed ID: 38673379
[No Abstract] [Full Text] [Related]
20. Serum concentrations of legacy and emerging per- and polyfluoroalkyl substances in the Anniston Community Health Surveys (ACHS I and ACHS II).
Petriello MC; Mottaleb MA; Serio TC; Balyan B; Cave MC; Pavuk M; Birnbaum LS; Morris AJ
Environ Int; 2022 Jan; 158():106907. PubMed ID: 34763231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
